Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Botta

Showing results (1-10 of 276) with videos related to

Pageof 28
Sort By:
Journal of Chemical Information and Modeling|June 26, 2007
Lennard-Jones potential and dummy atom settings to overcome the AUTODOCK limitation in treating flexible ring systemsStefano Forli, Maurizio Botta
Current Pharmaceutical Design|February 7, 2003
Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK)Fabrizio Manetti, Maurizio Botta
Current Pharmaceutical Design|December 17, 2010
Using insights into Pim1 structure to design new anticancer drugsSilvia Schenone, Cristina Tintori, Maurizio Botta
Current Pharmaceutical Design|August 31, 2011
Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapyMattia Mori, Fabrizio Manetti, Maurizio Botta
Current Topics in Medicinal Chemistry|April 8, 2010
Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligandsCristina Tintori, Fabrizio Manetti, Maurizio Botta
Anti-Cancer Agents in Medicinal Chemistry|November 30, 2007
Synthetic SRC-kinase domain inhibitors and their structural requirementsSilvia Schenone, Fabrizio Manetti, Maurizio Botta
Drug Discovery Today. Technologies|January 24, 2014
Small molecules modulation of 14-3-3 protein-protein interactionsMattia Mori, Giulia Vignaroli, Maurizio Botta
Journal of Chemical Information and Modeling|December 22, 2010
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulatorsMattia Mori, Fabrizio Manetti, Maurizio Botta
Organic & Biomolecular Chemistry|July 8, 2009
Recent highlights in the synthesis of highly functionalized pyrimidinesMarco Radi, Silvia Schenone, Maurizio Botta
Current Pharmaceutical Biotechnology|March 21, 2012
Allosteric inhibitors of Bcr-Abl: towards novel myristate-pocket bindersMarco Radi, Silvia Schenone, Maurizio Botta
Pageof 28

Showing results (1-10 of 276) with videos related to

Sort By:
Pageof 28
Journal of Chemical Information and Modeling|June 26, 2007
Lennard-Jones potential and dummy atom settings to overcome the AUTODOCK limitation in treating flexible ring systemsStefano Forli, Maurizio Botta
Current Pharmaceutical Design|February 7, 2003
Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK)Fabrizio Manetti, Maurizio Botta
Current Pharmaceutical Design|December 17, 2010
Using insights into Pim1 structure to design new anticancer drugsSilvia Schenone, Cristina Tintori, Maurizio Botta
Current Pharmaceutical Design|August 31, 2011
Targeting protein-protein and protein-nucleic acid interactions for anti-HIV therapyMattia Mori, Fabrizio Manetti, Maurizio Botta
Current Topics in Medicinal Chemistry|April 8, 2010
Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligandsCristina Tintori, Fabrizio Manetti, Maurizio Botta
Anti-Cancer Agents in Medicinal Chemistry|November 30, 2007
Synthetic SRC-kinase domain inhibitors and their structural requirementsSilvia Schenone, Fabrizio Manetti, Maurizio Botta
Drug Discovery Today. Technologies|January 24, 2014
Small molecules modulation of 14-3-3 protein-protein interactionsMattia Mori, Giulia Vignaroli, Maurizio Botta
Journal of Chemical Information and Modeling|December 22, 2010
Predicting the binding mode of known NCp7 inhibitors to facilitate the design of novel modulatorsMattia Mori, Fabrizio Manetti, Maurizio Botta
Organic & Biomolecular Chemistry|July 8, 2009
Recent highlights in the synthesis of highly functionalized pyrimidinesMarco Radi, Silvia Schenone, Maurizio Botta
Current Pharmaceutical Biotechnology|March 21, 2012
Allosteric inhibitors of Bcr-Abl: towards novel myristate-pocket bindersMarco Radi, Silvia Schenone, Maurizio Botta
Pageof 28